Gabriel Kristian Pedersen

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

Rebecca Jane Cox, Gabriel Kristian Pedersen, Abdullah S. Madhun et al. · Vaccine · 2011 · 101 citations

Vaccination, Matrix M™ Adjuvant, Vaccine Development +8

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo

Leo Hanke, Hrishikesh Das, Daniel J. Sheward et al. · Nature Communications · 2022 · 85 citations · Full text

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers

Abdullah S. Madhun, Per Espen Akselsen, Haakon Sjursen et al. · Vaccine · 2010 · 63 citations

Vaccination, Vaccine Safety, Cross-protection +11

Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP

Gabriel Kristian Pedersen, Thomas Ebensen, Ingrid Hjetland Gjeraker et al. · PLoS ONE · 2011 · 61 citations · Full text

Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses

Gabriel Kristian Pedersen, Katharina Wørzner, Peter Andersen et al. · Frontiers in Immunology · 2020 · 61 citations · Full text

Engineering, Germinal Center Responses, Immunology +20